Expression and Purification of Recombinant Respiratory Syncytial Virus Proteins
- PMID: 40879907
- DOI: 10.1007/978-1-0716-4666-3_10
Expression and Purification of Recombinant Respiratory Syncytial Virus Proteins
Abstract
Recombinant protein expression and purification are crucial for studying pathogen-host interactions, especially in therapeutic contexts. This chapter comprehensively overviews various expression systems and chromatography techniques to express and purify respiratory syncytial virus (RSV) proteins. These proteins include nonstructural protein 1 (NS1), nonstructural protein 2 (NS2), nucleoprotein (N), phosphoprotein (P), matrix protein (M), M2-1 protein, M2-2 protein, and the large RNA-dependent RNA polymerase protein (L). Choosing an appropriate expression system, such as bacterial E coli cells or insect cells, is critical for protein expression and will depend on the specific size and properties of the particular protein. Chromatography is a common technique in protein purification that leverages the protein's binding affinity, charge, hydrophobicity, or size, but it often requires significant optimization. We outline the protocol for expressing RSV proteins and detail the purification procedures using affinity chromatography, ion exchange chromatography, and size exclusion chromatography to achieve optimal purification of these RSV proteins.
Keywords: Affinity chromatography; E. coli cells; Insect cells; Ion exchange chromatography; L; M; M2–1; M2–2; N; NS1; NS2; P; Protein purification; Recombinant protein expression; Respiratory syncytial virus (RSV); Size exclusion chromatography.
© 2025. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.J Virol. 2020 Nov 23;94(24):e01831-20. doi: 10.1128/JVI.01831-20. Print 2020 Nov 23. J Virol. 2020. PMID: 32999025 Free PMC article.
-
Lethal model for respiratory syncytial virus infection using C57BL/6 mice.J Virol. 2024 Dec 17;98(12):e0177224. doi: 10.1128/jvi.01772-24. Epub 2024 Nov 5. J Virol. 2024. PMID: 39498987 Free PMC article.
-
Identification of distinct genotypes in circulating RSV A strains based on variants in the virus replication-associated genes.J Virol. 2024 Aug 20;98(8):e0099024. doi: 10.1128/jvi.00990-24. Epub 2024 Jul 15. J Virol. 2024. PMID: 39007617 Free PMC article.
-
Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review.Expert Rev Clin Immunol. 2025 Jun;21(6):745-760. doi: 10.1080/1744666X.2025.2494658. Epub 2025 May 2. Expert Rev Clin Immunol. 2025. PMID: 40278893
-
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review.Influenza Other Respir Viruses. 2021 Jul;15(4):539-551. doi: 10.1111/irv.12850. Epub 2021 Mar 25. Influenza Other Respir Viruses. 2021. PMID: 33764693 Free PMC article.
References
-
- (NCIRD), C (2022) RSV-NET database. CDC. https://www.cdc.gov/rsv/research/rsv-net/overview-methods.html
-
- Statistics, N.C.f.H (2024) Trends in deaths for viiral respiratory illness. CDC. https://www.cdc.gov/respiratory-viruses/data-research/dashboard/most-imp...
-
- Simoes EAF et al (2022) Prefusion F protein-based respiratory syncytial virus immunization in pregnancy. N Engl J Med 386(17):1615–1626 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials